References
- HaylenBTDe RidderDFreemanRMAn International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunctionNeurourol Urodyn201029142019941278
- IrwinDEMilsomIHunskaarSPopulation-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC studyEur Urol20065061306131417049716
- GarnettSSwithinbankLEllis-JonesJThe long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in womenBJU Int2009104794895319389015
- MalmstenUGMolanderUPeekerRIrwinDEMilsomIUrinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45–103 yearsEur Urol201058114915620356669
- AbramsPWeinAThe overactive bladder: a widespread but treatable conditionStockholmErik Sparre Medical AB1998
- BallertKNUnder treatment of overactive bladderJ Urol201018341282128320171673
- HelfandBTEvansRMMcVaryKTA comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patientsEur Urol201057458659120036783
- CohenSJRobinsonDDuganECommunication between older adults and their physicians about urinary incontinenceJ Gerontol A Biol Sci Med Sci1999541M34M3710026660
- de BoerTASalvatoreSCardozoLPelvic organ prolapse and overactive bladderNeurourol Urodyn2010291303920025017
- ResnickNYallaSVLaurinoEThe pathophysiology of urinary incontinence among institutionalized elderly personsN Engl J Med19893201172909873
- DigesuGAKhullarVCardozoLSalvatoreSOveractive bladder symptoms: do we need urodynamics?Neurourol Urodyn200322210510812579626
- KayGGEbingerUPreserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacinInt J Clin Pract200862111792180018699842
- OlshanskyBSpieringsEBrumJValidation of the differential cardiovascular effects of the antimuscarinic agents, darifenacin and tolterodine, in a randomized, placebo-controlled, 3-way crossover studyUro Today Int J200924
- CrookTHLebowitzBDPirozzoloFJRecalling names after introduction: changes across the adult life span in two culturesDev Neuropsychol199392103113
- MilsomIAbramsPCardozoLRobertsRGThuroffJWeinAJHow widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence studyBJU Int200187976076611412210
- US Department of Health and Human Services National Center for Health StatisticsCenters for Disease Control and Prevention and National Center for Health Statistics2009 Available from: http://www.cdc.gov/nchs/.
- NyeAMClinardVBBarnesCLMedication nonadherence secondary to drug-induced memory lossConsult Pharm201025211712120211824
- StaskinDKayGTannenbaumCTrospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladderInt J Clin Pract20106491294130020561092
- WesnesKAEdgarCTretterRNBolodeokuJExploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mgExpert Opin Drug Saf20098661562619747069
- AncelinMLArteroSPortetFDupuyAMTouchonJRitchieKNon-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort studyBMJ2006332753944544916473859
- DuBeauCETreatment of OAB in geriatric patientsClin Geriatr200715Suppl 246
- AnderssonKESarawateCKahlerKHStanleyELKulkarniASCardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladderBJU Int2010106226827419922546
- RodenDMDrug-induced prolongation of the QT intervalN Engl J Med2004350101013102214999113
- SchiffersMSauermannPSchurchBThe effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjectsWorld J Urol201028565165620140437
- HozawaAOhkuboTKikuyaMPrognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama studyAm J Hypertens20041711 Pt 11005101015533725